Chongqing Xishan Science & Technology Valuation

Q: What is the Fair Price of 688576 when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.

688576 (CN¥63.03) is trading below our estimate of [[fair value]] (CN¥72.19)

Is 688576 undervalued compared to its fair value, analyst forecasts and its price relative to the market?

Valuation Score

4/6

Valuation Score 4/6

Below Fair Value
Significantly Below Fair Value
Price-To-Earnings vs Peers
Price-To-Earnings vs Industry
Price-To-Earnings vs Fair Ratio
Analyst Forecast

Share Price vs Fair Value

What is the Fair Price of 688576 when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.

Below Fair Value: 688576 (CN¥63.03) is trading below our estimate of fair value (CN¥72.19)

Significantly Below Fair Value: 688576 is trading below fair value, but not by a significant amount.

Key Valuation Metric

Which metric is best to use when looking at relative valuation for 688576?

Key metric: As 688576 is profitable we use its Price-To-Earnings Ratio for relative valuation analysis.

The above table shows the Price to Earnings ratio for 688576. This is calculated by dividing 688576's market cap by their current earnings.
What is 688576's PE Ratio?
PE Ratio	24.9x
Earnings	CN¥118.39m
Market Cap	CN¥2.95b

688576 key valuation metrics and ratios. From Price to Earnings, Price to Sales and Price to Book to Price to Earnings Growth Ratio, Enterprise Value and EBITDA.
Key Statistics
Enterprise Value/Revenue	5.5x
Enterprise Value/EBITDA	23.6x
PEG Ratio	0.9x

Price to Earnings Ratio vs Peers

How does 688576's PE Ratio compare to its peers?

The above table shows the PE ratio for 688576 vs its peers. Here we also display the market cap and forecasted growth for additional consideration.
Company	Forward PE	Estimated Growth	Market Cap
Peer Average	34.1x
301033 Medprin Regenerative Medical Technologies	44.7x	28.5%	CN¥3.0b
301235 Wuhan Huakang Century Medical	33.2x	n/a	CN¥2.2b
300314 Ningbo David Medical Device	39.8x	42.0%	CN¥3.5b
300396 Dirui IndustrialLtd	18.6x	40.5%	CN¥4.4b
688576 Chongqing Xishan Science & Technology	24.9x	28.4%	CN¥3.0b

Price-To-Earnings vs Peers: 688576 is good value based on its Price-To-Earnings Ratio (24.9x) compared to the peer average (34.1x).

Price to Earnings Ratio vs Industry

How does 688576's PE Ratio compare vs other companies in the CN Medical Equipment Industry?

0 Companies	Price / Earnings	Estimated Growth	Market Cap

No more companies available in this PE range

0 Companies		Estimated Growth	Market Cap

No more companies

Price-To-Earnings vs Industry: 688576 is good value based on its Price-To-Earnings Ratio (24.9x) compared to the CN Medical Equipment industry average (35x).

Price to Earnings Ratio vs Fair Ratio

What is 688576's PE Ratio compared to its Fair PE Ratio? This is the expected PE Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.

688576 PE Ratio vs Fair Ratio.
Fair Ratio
Current PE Ratio	24.9x
Fair PE Ratio	26x

Price-To-Earnings vs Fair Ratio: 688576 is good value based on its Price-To-Earnings Ratio (24.9x) compared to the estimated Fair Price-To-Earnings Ratio (26x).

Analyst Price Targets

What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?

Analyst Forecast: Insufficient data to show price forecast.

Discover undervalued companies

Shenzhen Lifotronic Technology

CN¥6.7b

Research, develops, manufactures, and markets medical devices for diagnostics, clinical medicine, skin, and human health related purposes in China.

688389

CN¥15.65

-6.0%

-35.5%

Winner Medical

CN¥19.7b

Engages in the research and development, manufacture, and marketing of cotton-based medical dressings and medical disposables, and consumer products in China.

300888

CN¥33.84

-1.3%

-14.3%

Truking Technology

CN¥4.6b

Engages in medical equipment business in China and internationally.

300358

CN¥7.73

-0.4%

-34.9%